Inventor · disambiguated record
Takahiko Taniguchi
Also filed as: TANIGUCHI TAKAHIKO
22 granted patents·6 pending applications·67 citations·filing 2006–2024
94Inventor score
Files withTANIGUCHI TAKAHIKO11TAKEDA PHARMACEUTICALS CO9TAKEDA PHARMACEUTICAL5HASUI TOMOAKI1RAKER JOSEPH1
Top patents by PatentIndex Score
28 records- 0188US8354411B21-phenyl-3-pyrazolylpyridazin-4(1H)-one compoundTAKEDA PHARMACEUTICAL·Filed 2010·Granted Jan 15, 2013·9 cites·1 claims
- 0285US8513251B2Pyridazinone compoundsTANIGUCHI TAKAHIKO·Filed 2012·Granted Aug 20, 2013·6 cites·1 claims
- 0385US8435995B2Pyridazinone compoundsTANIGUCHI TAKAHIKO·Filed 2012·Granted May 7, 2013·6 cites·1 claims
- 0482US8778944B2Pyridazinone compoundsTANIGUCHI TAKAHIKO·Filed 2012·Granted Jul 15, 2014·5 cites·38 claims
- 0581US8916566B2Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disordersTANIGUCHI TAKAHIKO·Filed 2010·Granted Dec 23, 2014·4 cites·37 claims
- 0679US7803822B2Triazole derivative and use thereofTAKEDA PHARMACEUTICAL·Filed 2006·Granted Sep 28, 2010·6 cites·10 claims
- 0778US9150588B2Substituted pyridazin-4(1H)-ones as phosphodiesterase 10A inhibitorsTANIGUCHI TAKAHIKO·Filed 2011·Granted Oct 6, 2015·5 cites·9 claims
- 0878US9090586B2Heterocyclic compoundYOSHIKAWA MASATO·Filed 2011·Granted Jul 28, 2015·5 cites·12 claims
- 0978US8563575B2Fused heterocyclic compoundsTANIGUCHI TAKAHIKO·Filed 2011·Granted Oct 22, 2013·4 cites·15 claims
- 1077US9550756B2Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disordersTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Jan 24, 2017·2 cites·37 claims
- 1175US8940758B2Fused heterocyclic compoundsTAKEDA PHARMACEUTICAL·Filed 2013·Granted Jan 27, 2015·2 cites·17 claims
- 1275US8846713B2Fused heterocyclic compounds as phosphodiesterases (PDEs) inhibitorsTANIGUCHI TAKAHIKO·Filed 2011·Granted Sep 30, 2014·2 cites·2 claims
- 1374US9226921B2Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitorsTAKEDA PHARMACEUTICAL·Filed 2014·Granted Jan 5, 2016·2 cites·17 claims
- 1470US8883788B2Fused heterocyclic ring compoundHASUI TOMOAKI·Filed 2011·Granted Nov 11, 2014·4 cites·8 claims
- 1569US9469637B2Nitrogenated heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted Oct 18, 2016·1 cites·2 claims
- 1668US9527841B2Substituted pyrido[2,3-b]pyrazines as phosphodiesterase 2A inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted Dec 27, 2016·2 cites·10 claims
- 1765US9579407B2Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (PDE10A) in mammalsTANIGUCHI TAKAHIKO·Filed 2012·Granted Feb 28, 2017·1 cites·12 claims
- 1865US9029388B2Condensed heterocyclic compoundTANIGUCHI TAKAHIKO·Filed 2012·Granted May 12, 2015·1 cites·13 claims
- 1963US2024309016A1Macrocyclic heterocycle compounds and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 2062US2024217957A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 2158US2017114044A1Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disordersTAKEDA PHARMACEUTICALS CO·Filed 2016·Application pending·0 cites
- 2247US8575167B2Spiro compounds having stearoyl-CoA desaturase actionTANIGUCHI TAKAHIKO·Filed 2008·Granted Nov 5, 2013·0 cites·11 claims
- 2346US2009325956A1Aromatic amine derivative and use thereofTANIGUCHI TAKAHIKO·Filed 2007·Application pending·0 cites
- 2444US10017508B2Nitrogenated heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jul 10, 2018·0 cites·11 claims
- 2544US2016159808A1Heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2014·Application pending·0 cites
- 2644US2016264536A1Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2014·Application pending·0 cites
- 2737US9944596B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Apr 17, 2018·0 cites·23 claims
- 2831US9029536B2Fused heterocyclic compoundsRAKER JOSEPH·Filed 2011·Granted May 12, 2015·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Takahiko Taniguchi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →